Search - tctmd.com

Displaying 481 - 500 of 648

Sort: Relevancy | Date

Presentation

Clinical Outcomes of the First Randomized Clinical Trial Evaluating a Dedicated Bifurcation Stent

Presenter: Martin Leon

October 31, 2013

Presentation TCT 2013

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

TRYTON: A Prospective, Randomized Trial of a Dedicated Side Branch Stent vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

Interventional Cardiovascular Medicine Perspectives

Presenter: Martin Leon

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Presentation TCT 2013

TCT at 25: Historical Perspectives

Presenter: Martin Leon

October 29, 2013

Presentation

TAVR vs. Surgery in Intermediate Risk Patients

Presenter: Martin Leon

October 29, 2013

News Conference News TCT 2013

Memories of TCT from the Beginning: Martin B. Leon, MD

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

Presentation TCT 2013

A Review of New Aortic Valvuloplasty Systems: interValve, Loma Vista, Cardiosculpt, and PiR2

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

Opening Speaker: 25 Years of TCT: Evolution of a Sub-Specialty

Presenter: Martin Leon

October 28, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

Advertisement

Clinical Outcomes of the First Randomized Clinical Trial Evaluating a Dedicated Bifurcation Stent

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

TRYTON: A Prospective, Randomized Trial of a Dedicated Side Branch Stent vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

Interventional Cardiovascular Medicine Perspectives

Two Trials to Assess TAVR in Moderate-Risk Patients

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

TCT Leadership Outlines the State of Intervention

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

TCT at 25: Historical Perspectives

TAVR vs. Surgery in Intermediate Risk Patients

Memories of TCT from the Beginning: Martin B. Leon, MD

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

A Review of New Aortic Valvuloplasty Systems: interValve, Loma Vista, Cardiosculpt, and PiR2

The Valve Medical TAVR System (Israel)

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Opening Speaker: 25 Years of TCT: Evolution of a Sub-Specialty

Memories of TCT 1988 and Beyond: Marvin L. Woodall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content